AYTU BIOPHARMA, INC Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
AYTU BIOPHARMA, INC (AYTU) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $428.37 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2017-08-31.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2017-08-31
- AYTU BIOPHARMA, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2017-06-30 was $0.00.
- AYTU BIOPHARMA, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2016-06-30 was $0.00.
- AYTU BIOPHARMA, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2017 was $428.37K.
- AYTU BIOPHARMA, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2016 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $428.37K 10-K · filed 2017-08-31 | |
| 2017-03-31 | $428.37K 10-Q · filed 2017-05-11 | ||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $0.00 10-K · filed 2017-08-31 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |